Study title |
Treatment Factors Associated With Survival in Early-Stage Oral Cavity Cancer |
journal |
JAMA Otolaryngology- Head and Neck Surgery |
study year |
2015 |
QUESTION |
Is there an association between treatment variables and survival in stage I and II oral cavity squamous cell carcinoma (OCSCC)? |
Study DESIGN |
Retrospective cohort study |
STUDY GROUPS |
Factors investigated: Radiation therapy, chemotherapy, neck dissection, surgical margins, hospital type/case volume, insurance |
Population |
Patients with stage I or II OCSCC (n=6,830) |
Inclusion criteria |
Patients with stage I or II OCSCC |
Exclusion criteria |
Patients who did not undergo surgery Multiple malignant primary tumours Undocumented pathologic stage |
Follow-up |
N/A |
Primary endpoint(s) |
5-year survival: - Neck dissection, no radiotherapy, no chemotherapy, case volume >10/year and negative tumour margins all beneficial (p=0.001 for all) Overall survival: - Neck dissection (p=0.003), no radiotherapy (p<0.001), no chemotherapy (p=0.03), academic institution (p=0.03) and negative tumour margins (p=0.005) all beneficial |
Secondary endpoint(s) |
N/A |
Weblink |
https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/2291044 |
Brief summary |
Patients who underwent END had greater survival, reflecting restaging and elimination of patients with occult nodal disease. Positive margins independently associated with decreased survival. |
Authors |
Luryi et al Department of Surgery, Yale University School of Medicine, USA |